Twist Bioscience Corporation - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
TWST Nasdaq 2836 www.twistbioscience.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Twist Bioscience Corporation

Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue - Jan 12th, 2026 6:00 am
Twist Bioscience (TWST) Valuation Check After TD Cowen Buy Rating And Raised Outlook - Jan 10th, 2026 5:18 pm
Cathie Wood Doubles Down on Biotech as 2025 Ends, Offloads Rocket Lab - Dec 31st, 2025 4:26 am
Barclays Keeps Its Overweight Rating On Twist Bioscience Corporation (TWST) - Dec 30th, 2025 9:48 pm
TSLA: Cathie Wood Dumps $30 Million Worth Tesla Stock - Dec 29th, 2025 10:51 am
New Product Launch Strengthens Bull Case for Twist Bioscience ( TWST) - Dec 22nd, 2025 8:20 pm
Twist Bioscience to Present at J.P. Morgan 2026 Healthcare Conference - Dec 18th, 2025 6:00 am
Twist Bioscience (TWST): Valuation Check After New Research-Grade Plasmid DNA Preps Boost Investor Interest - Dec 4th, 2025 5:14 pm
How Twist’s New Preclinical-Grade Plasmid DNA Preps Could Reshape the TWST Nucleic Acid Therapeutics Story - Dec 4th, 2025 2:09 pm
Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics Research - Dec 4th, 2025 6:00 am
Company News for Nov 18, 2025 - Nov 18th, 2025 7:40 am
Stephens Initiates Twist Bioscience (TWST) With Overweight Rating, Sets $41 PT - Nov 18th, 2025 2:45 am
Is Twist Bioscience Corporation (TWST) a Compelling Risk-Regarded Opportunity? - Nov 17th, 2025 8:13 am
Twist Bioscience (TWST) Is Down 11.2% After Record Revenue and MRD Express Launch Plans Announced - Nov 16th, 2025 4:10 am
Twist Bioscience Corp (TWST) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ... - Nov 14th, 2025 12:01 pm
Twist Bioscience (TWST) Reports Q4 Loss, Tops Revenue Estimates - Nov 14th, 2025 6:25 am
Twist Bioscience: Fiscal Q4 Earnings Snapshot - Nov 14th, 2025 5:34 am
Twist Bioscience Announces Fiscal 2025 Fourth Quarter and Full Year Financial Results - Nov 14th, 2025 5:15 am
Ovid Therapeutics (OVID) Reports Q3 Loss, Lags Revenue Estimates - Nov 12th, 2025 6:10 am
Twist Bioscience (TWST): Exploring Valuation Following Fresh Analyst Coverage and Product Launch Collaboration - Nov 6th, 2025 12:09 am